Clinical Challenges of Pediatric MS
Season 3, Ep. 8
Pediatric multiple sclerosis. How different is the disease from adult MS? Which disease-modifying therapies have been trialed and approved for use in children? How common iscognitive impairmentin children with MS? How can it be successfully addressed?These are some of the important questions Drs.ZongqiXia andKavita Thakkarfrom theUniversity of Pittsburgh Medical Centerdiscuss in this clinically focusedeMultipleSclerosisReview podcast.Take ourpost-testto claim CME credits.To read a companion newsletterclick here.
Clinical Decisions: Selecting the Right Disease Modifying Therapy
Season 3, Ep. 6
Selectingthe most appropriateDisease Modifying Therapy (DMT)is becoming more complicated forpatients with MS and clinicians who treat them. Newer approaches and newer agents are altering the benefit/riskequation, andmaking the question ofwhich treatment ismost appropriatefor which patientmore difficult to answer. That’s the focus of our discussion with Dr.Erin Longbrake, Assistant Professor of Neurology and Director of the Multiple Sclerosis Fellowship Program at Yale University, in thiseMultipleSclerosisReview podcast. Take our post-test to claim CME credits.To read a companion newsletterclick here.
Clinic Insight — Managing Chronic MS Symptoms
Season 3, Ep. 4
Successful management of multiple sclerosis has gone beyond slowing disease progression and preventing relapses. Improving patients’ health-related quality of life by recognizing and addressing the pervasive chronic symptoms of the disease — spasticity, fatigue, depression, cognitive dysfunction — has become increasingly important. In thiseMultipleSclerosisReview Podcast, Dr.BardiaNourbakhshfrom the Johns Hopkins School of Medicine provides clinical insight into reducing the disease burden of these common symptoms. Take our post-test to claim CME credits.To read a companion newsletterclick here.
Minimizing Pregnancy/Postpartum Relapses: A Clinical Perspective
Season 3, Ep. 2
Disease reactivation during and after pregnancy is a challenge facing many women with MS and their clinicians.How can relapses be prevented?What are the benefits of pregnancy planning? What are therisk factors for postpartum MSreactivation? How can they be modified? These are the questionsDr.Kristen Kryskofrom theUniversity of California San Franciscoaddresses in thiseMultipleSclerosisReview podcast. Take our post-test to claim CME credits. To read a companion newsletterclick here.
Individualizing MS Treatment: Practical Applications
Season 2, Ep. 6
In this podcast, Drs. Daniel Ontaneda, Jenny Feng and Gabrielle Macaron from the Cleveland Clinic follow up on their recent eMS Newsletter Issue (V2; No.5) to discuss some of the practical applications of individualizing MS therapy. Take ourpost-testto claim CME credits. To read a companion newsletterclick here.
Patients’ DMT Decision-Making
Season 2, Ep. 4
In this issue, Dr. Ellen Mowry, Associate Professor of Neurology and Epidemiology at the Johns Hopkins University School of Medicine, brings recent findings about patient decision-making and addressing common comorbidities into the MS clinic. Take ourpost-testto claim CME credits. To read a companion newsletterclick here.
Clinical Markers for MS Diagnosis and Prognosis
Season 2, Ep. 2
The central vein sign. Optical coherence tomography. Serum neurofilament light chain. New research has identified these markers as valuable in discriminating MS from mimicking conditions, and in predicting future disability. In this Issue, Dr. Michael Kornberg and Dr. Elias Sotirchos from the Johns Hopkins University School of Medicine discuss how these advances can impact clinical decision-making to provide better patient care. Take ourpost-testto claim CME credits. To read a companion newsletterclick here.
Incorporating MRI Results in Treatment Decision Making
Season 1, Ep. 6
Benjamin M. Greenberg, MD, MHS covers the important topic of Incorporating MRI Results in Treatment Decision Making in the format of case-study scenarios for the clinical practice. To read a companion newsletter click here.